A 49-year-old Omaha woman has pleaded guilty to committing a wire fraud that took more than $4.6 million from Children's Hospital and Medical Center in Omaha in a complicated scheme where she submitted invoices for Broxcilam, a drug she made up.
Lisa Kwapniowski could get up to 20 years in federal prison at her sentencing April 29.
She also will be ordered to pay $4,622,234 in restitution and has agreed to forfeit her interest in a home she owns in Omaha.
In a news release Monday, U.S. Attorney Joe Kelly said that from 2010-18, Kwapniowski, the former director of pharmacy services for Children’s Hospital, submitted fraudulent invoices from legitimate pharmaceutical suppliers and from a company she created.
You have free articles remaining.
Among other things, in early 2012, Kwapniowski set up a business she named RxSynergy and began to submit invoices purported to be for pharmaceuticals and supplies that neither she nor the company provided. A number of the invoices were for a drug called Broxcilam, which was not a real drug.
By 2018, Kwapniowski had submitted at least 227 fraudulent invoices.
The case was investigated by the FBI.
Last month, her pharmacist license was revoked for a minimum of two years as a result of the allegations against her.